본문바로가기
메뉴바로가기

Global riactice Leader's in Brain Science

Board

  • Major event
  • Notice
  • Seminar
  • Photo Gallery
  • News
  • Application Form
  • FAQ
  • Q&A

Home > Board > Seminar

Seminar

10/11 (Thu) 16:00 Special Seminar
Name : 관리자 | Date : 2018.10.10 10:01 | Views : 4171

Title: Quest to Cure Krabbe Disease


Speaker: Daesung Shin, Ph.D., Hunter James Kelly Research Institute, State University of New York (Host : Myungin Baek)


Time: 16:00, October 11 (Thu), 2018
        

Venue: Room 114, Building E4, DGIST


Abstract : Krabbe Disease (KD, also known as ‘globoid cell leukodystrophy’) is a fatal lysosomal storage disorder caused by mutations in galactosylceramidase (GALC), which cause demyelinating neurodegeneration. Unfortunately, there is no cure for KD and we have a limited understanding of KD pathogenesis. Hematopoietic stem cell transplantation (HSCT) partially attenuates the course of KD only if performed before the onset of symptoms, presumably because stem cell derivatives secrete GALC that is uptaken by myelinating glia. However, it is not clear if only myelin-forming glia need to be corrected and at which developmental stage. Furthermore, accumulation of the lipid psychosine due to GALC deficiency contributes to KD by killing myelin-forming glia and neurons, but the relative importance of psychosine, its origin and the sequence of pathogenic events is unclear. We recently developed a conditional Galc floxed mouse and found that: 1) A KD phenotype is delayed (~25 days) when Galc ablation is induced ubiquitously [Galc-iKO] after postnatal day (P) 6, as compared to induction at P4 or before, suggesting that there is a defined vulnerable period in which GALC deficiency initiates KD pathogenesis; 2) Oligodendrocyte (OL)-specific Galc conditional knockout [Galc-CKO] causes tremor, wasting, motor defects, demyelination with substantial psychosine accumulation, but milder pathology than Galc-iKO mice, suggesting that Galc deficiency in OLs alone may not be sufficient to trigger a complete KD phenotype. These findings are important to define the therapeutic window to treat and allow the identification of novel specific target cells for therapy.


Person in charge : Sora Lee


Contact: srlee@dgist.ac.kr, 053)785-6102

IP : 10.140.1.*** share
QRcode
  • twitter
  • facebook
  • me2day
  • yozm
  • clog
  • delicious
Attachments
%s1 / %s2
 
List Gallery Webzine RSS FEED

No File Subject Name Date Views
png 관리자 2019.02.19 14,075
125 pdf 관리자 2019.01.25 6,193
124 pdf 관리자 2019.01.24 3,156
123 pdf 관리자 2019.01.24 3,116
122 pdf 관리자 2019.01.24 3,116
121 pdf 관리자 2018.12.06 3,318
120 pdf 관리자 2018.11.20 3,261
119 pdf 관리자 2018.11.15 3,357
118 pdf 관리자 2018.11.15 3,334
117 pdf 관리자 2018.10.15 3,474
116 pdf 관리자 2018.10.11 3,418
115 pdf 관리자 2018.10.11 4,081
pdf 관리자 2018.10.10 4,172
113 pdf 관리자 2018.10.02 4,193
112 pdf 관리자 2018.09.10 4,316
111 pdf 관리자 2018.09.10 4,090
110 pdf 관리자 2018.08.29 4,285
109 jpg 관리자 2018.08.20 11,302
108 pdf 관리자 2018.07.26 9,186
107 pdf 관리자 2018.07.16 9,196
106 pdf 관리자 2018.06.21 10,375